Swiss Tropical and Public Health Institute (Swiss TPH)
Swiss Tropical and Public Health Institute (Swiss TPH)
Consultation date: 15 October 2014
Malaria elimination strategy
The Swiss Tropical and Public Health Institute (Swiss TPH) seeks to achieve significant improvements of human health and well-being through a better understanding of diseases and health systems, and to act on this knowledge. By focusing on research, teaching and service provision in low and middle income countries, the Swiss TPH aims to improve public health, strengthen health systems and reduce poverty.
The overarching malaria strategy of Swiss TPH focuses on topics ranging from basic science (immunology and molecular biology) to the development of new vaccines and health interventions, screening of drug candidates, testing new products, and their implementation within programmatic conditions.
Malaria research projects at the institution have a near to global outreach, with malaria research operating in Tanzania, the Democratic Republic of Congo, and in Côte d’Ivoire among many other African countries. In addition, the Swiss TPH has partnered with the Harvard University and ISGlobal to provide leadership development courses on the science of malaria eradication.
Funding 1 project(s)
Leading 21 project(s)
Swiss Tropical and Public Health Institute (Swiss TPH) , University of São Paulo | Ingrid Felger, Marcelo Urbano Ferreira
May 2012 to Jun 2014
Population structure and transmission dynamics of Plasmodium vivax: regional and global perspective (Brazilian Swiss Joint Research Program)
Swiss Tropical and Public Health Institute (Swiss TPH) , Swiss Centre for International Health (SCIH) | Kate Molesworth, Leah F. Bohle, Ally-Kebby Abdallah
May 2014
Knowledge, attitudes and perceptions towards malaria diagnostics in Kondoa District, Tanzania. A multi-method cross-sectional pilot approach
Papua New Guinea Institute of Medical Research (IMR), Swiss Tropical and Public Health Institute (Swiss TPH) | Justin Pulford, Manuel Hetzel, Peter Siba
Evaluation of the National Malaria Control Program
Oct 2013 to Sep 2016
Establishment of an interaction network of exported proteins in Plasmodium falciparum
Jan 2006 to May 2014
Drug discovery for malaria based on novel drug targets in the NGBS Consortium (Novartis Institute for Tropical Diseases, Genomic Institute of the Novartis Research Foundation, Biomedical Primate Research Center and Swiss TPH)
May 2011 to Mar 2016
Further development of simulations of Plasmodium falciparum interventions and their integration with the needs of stakeholders
Swiss Tropical and Public Health Institute (Swiss TPH) , Ifakara Health Institute (IHI) | Sarah J. Moore
Apr 2015 to Sep 2017
Randomized Control Trial of Permethrin Treated Uniforms (PTU) and 30% DEET Skin Repellents to Reduce Malaria Incidence in Military Personnel on Active Duty in Regions of Hyperendemicity
Jan 2014 to Dec 2017
Estimating the extent, patterns and consequences of heterogeneity in malaria dynamics
Epidemiology of ultra-low density malaria infections and their relevance for control and elimination
Oct 2010 to Sep 2013
Proteomic analysis and studies of interactions of exported proteins in Plasmodium falciparum
Sep 2010 to Mar 2012
Development of National Malaria Elimination Strategy and M&E plan for National Malaria Elimination Programme (NMEP) of the Republican Tropical Diseases Centre of Tajikistan
Apr 2011 to Apr 2015
Molecular tools for monitoring the impact of intensified malaria control on malaria epidemiology
Partnering on 17 project(s)
Jan 2013 to Dec 2014
Responding to Efficacy Decay Analysis of Artemisinin-based Combination Therapy (ACT) for Malaria Treatment in Rural Tanzania: Intervening on Access
Jun 2012 to Jul 2017
Mal067- Understanding RTS,S malaria vaccine-induced protection through integrated analysis of antibody, B cell and T cell immune responses
Understanding human, parasite, vector and environmental interactions driving residual malaria transmission in Papua New Guinea
Jan 2013 to Dec 2014
Identifying correlates of protection to accelerate vaccine trials: systems evaluation of two models of experimentally-induced immunity to malaria (SysMalVac)
Nov 2012 to Jan 2015
Safety and Immunogenicity of P27A, a novel candidate blood-stage malaria vaccine, in malaria exposed African adults
Save the Children, World Vision, International Rescue Committee, Malaria Consortium, Society for Family Health (SFH)
Apr 2012 to Mar 2017
Rapid Access Expansion 2015 programme (RAcE 2015)
Jan 2013 to Apr 2016
Defining mosquito-to-man transmission of P. falciparum and P. vivax: Evaluation of epidemiological, molecular and serological markers in longitudinal cohorts in Brazil, Thailand, Solomon Islands and Papua New Guinea (based on TransEPI Consortium)
Oct 2009 to Oct 2013
Effectiveness and Safety Studies of Antimalarials in Africa (INESS) - Tanzania, Ghana, Burkina Faso, Mozambique
Barcelona Institute for Global Health (ISGlobal), National Institute of Allergy and Infectious Diseases (NIAID), NIH | Carlota Dobaño
2013 to 2015
Pilot phase for the MAL067 RTS,S immunology ancillary study
Videographic analysis of mosquito host-seeking behaviours around humans and odour-baited mosquito control traps
Apr 2014 to Mar 2019
Targeting residual malaria vectors in communities where insecticidal bed nets are already widely used
Centre for Research in Therapeutic Sciences (CREATES), Strathmore University, Kenya Medical Research Institute (KEMRI) | Bernhards Ogutu
Dec 2012 to Nov 2014
Platform for Controlled Human Malaria infection studies for development of new malaria vaccines, drugs and diagnostics in Africa (CHMI)